SignatureFD’s Collegium Pharmaceutical COLL Stock Holding History

SignatureFD’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.11K	Sell	86 -155	-64%	-$5.3K	﹤0.01%	3020
2026 Q1	$7.97K	Hold	241	–	–	﹤0.01%	2606
2025 Q4	$11.2K	Buy	241 +148	+159%	+$6.19K	﹤0.01%	2383
2025 Q3	$3.25K	Buy	93 +81	+675%	+$2.82K	﹤0.01%	2801
2025 Q2	$355	Sell	12 -82	-87%	-$2.34K	﹤0.01%	3151
2025 Q1	$2.81K	Buy	94 +33	+54%	+$1.01K	﹤0.01%	2786
2024 Q4	$1.75K	Sell	61 -150	-71%	-$4.96K	﹤0.01%	2911
2024 Q3	$8.15K	Buy	211 +150	+246%	+$5.35K	﹤0.01%	2416
2024 Q2	$1.96K	Sell	61 -62	-50%	-$2.15K	﹤0.01%	2760
2024 Q1	$4.78K	Buy	123 +52	+73%	+$1.82K	﹤0.01%	2554
2023 Q4	$2.19K	Hold	71	–	–	﹤0.01%	2732
2023 Q3	$1.59K	Hold	71	–	–	﹤0.01%	2835
2023 Q2	$1.53K	Sell	71 -13	-15%	-$295	﹤0.01%	2878
2023 Q1	$2.02K	Hold	84	–	–	﹤0.01%	2798
2022 Q4	$1.95K	Buy	84 +13	+18%	+$262	﹤0.01%	2822
2022 Q3	$1K	Sell	71 -66	-48%	-$1.16K	﹤0.01%	2931
2022 Q2	$2K	Buy	137 +100	+270%	+$1.68K	﹤0.01%	2721
2022 Q1	$1K	Buy	+37	New	+$699	﹤0.01%	2962

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

SignatureFD's COLL Position: Q2 2026 in Review

SignatureFD reduced its Collegium Pharmaceutical (COLL) stake by 64% in Q2 2026, selling an estimated $5.3K and leaving 86 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #3020.

SignatureFD first reported a position in COLL in Q1 2022 and has held it in 18 quarters since. The position peaked at $11.2K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

SignatureFD held 86 shares of Collegium Pharmaceutical worth $3.11K as of Q2 2026.
SignatureFD sold 155 Collegium Pharmaceutical shares in Q2 2026, an estimated $5.3K.
Collegium Pharmaceutical made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3020 holding.
SignatureFD first reported a position in Collegium Pharmaceutical in Q1 2022 and has held it in 18 quarters since.
SignatureFD's Collegium Pharmaceutical position peaked at $11.2K in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.